An operation-level prospective study of risk factors associated with the incidence density of lameness in Michigan (USA) equine operations

A prospective cohort study of lameness in Michigan equids was conducted using the Michigan Equine Monitoring System (MEMS) Phase-II database. MEMS Phase II was an equine health-monitoring study of 138 randomly-selected Michigan equine operations. Management and health-related data were collected for operations in two 12-month periods. The median incidence density of lameness was 2.8 cases per 10000 horse-days at-risk (Minimum = 0; 25th Quartale (Q) = 0; 75th Q = 10.2; Maximum = 48.5). Equine operation-management and environmental risk factors associated with the incidence density of lameness were assessed using multivariable Poisson regression. Management risk factors associated with the incidence density of lameness included the total operation horse-days monitored (3rd Q: Relative Risk (RR) = 0.46; 95% Confidence Interval (CI): 0.29–0.71 and 4th Q: RR = 0.24; 95% CI: 0.16–0.37), the veterinary-related services score (3rd Q: RR = 0.61; 95% CI: 0.39–0.96 and 4th Q: RR = 1.45; 95% CI: 1.01–2.08), the farrier-related services score (4th Q: RR = 1.60; 95% CI: 1.07–2.42) and operations having equids participating in exercise-related activities (RR = 1.71; 95% CI: 1.16–2.50). Environmental risk factors associated with the incidence density of lameness included operations with stalls having medium flooring (RR = 0.48; 95% CI: 0.35–0.65), operations with stalls having loose flooring (RR = 2.78; 95% CI: 1.88–4.10) and operations using straw-like materials for stall bedding (RR = 2.02; 95% CI: 1.53–2.68).     

Seroprevalence of Coxiella burnetii in selected populations of domestic ruminants in Newfoundland

The seroprevalence of Coxiella burnetii among cattle, sheep, and goats in Newfoundland was determined by microimmunofluorescence. Seropositivity to phase II antigen increased in sheep from 3.1% in 1997 to 23.5% in 1999-2000 (P < 0.001). Cows (24%) had antibodies to phase I antigen; goats (15.6%) had antibodies to phase II antigen. Seroprevalence of C. burnetii is increasing among sheep.     

Nutrient database for distiller's dried grains with solubles produced from new ethanol plants in Minnesota and South Dakota

A study was conducted to evaluate the nutrient content and variability of distiller's dried grains with solubles (DDGS) originating from new (less than 5 yr old) ethanol plants in Minnesota and South Dakota. Ten plants (8 MN, 2 SD) participated in the study, submitting a total of 118 samples. Samples were collected every 2 mo from ten ethanol plants in the Minnesota-South Dakota (MNSD) region from 1997 to 1999 and were analyzed for amino acid levels, DM, CP, crude fiber, crude fat, ash, ADF, NDF, Ca, P, K, Mg, S, Na, Zn, Mn, Cu, and Fe analysis. Digestible energy (DE), ME, and NFE levels were also calculated. Means (dry-matter basis) and coefficients of variation for each nutrient among all plants during 1997 to 1999 were DM (88.9%, 1.7%), CP (30.2%, 6.4%), crude fat (10.9%, 7.8%), crude fiber (8.8%, 8.7%), ash (5.8%, 14.7%), NFE (45.5%, 6.1%), ADF (16.2%, 28.4%), NDF (42.1%, 14.3%), calculated DE (3,990 kcal/kg, 3.24%), calculated ME (3,749 kcal/kg, 3.28%), Arg (1.20%, 9.1%), His (0.76%, 7.8%), Ile (1.12%, 8.7%), Leu (3.55%, 6.4%), Lys (0.85%, 17.3%), Met (0.55%, 13.6%), Phe (1.47%, 6.6%), Thr (1.13%, 6.4%), Trp (0.25%, 6.7%), Val (1.50%, 7.2%), Ca (0.06%, 57.2%), and P (0.89%, 11.7%), respectively. Among the amino acids analyzed, Lys was the most variable (CV = 17.3%), followed by Met (CV = 13.6%). Nutrient levels of MNSD DDGS were higher in crude fat, NDF, DE, ME, P, Lys, Met, and Thr and lower for DM, ADF, and Ca than NRC (1998) values. Nutrient values differed between years for ash, DE, Mn, Zn, Cys (P < 0.10), Fat, TDN, ME, Met, Ile (P < 0.05), Ca, P, K, Mg, and Cu (P < 0.01). These results suggest that gross energy; P; and total Lys, Met, and Thr levels are higher in DDGS from MNSD ethanol plants compared to published values and chemical analysis values of a DDGS sample obtained from an older Midwestern plant.     

A retrospective multi‐center study of treatment,outcome, and prognostic factors in 34 dogs with disseminated aspergillosis in Australia

BackgroundDisseminated aspergillosis (DA) in dogs has a guarded prognosis and there is a lack of a gold standard treatment protocol.ObjectiveTo retrospectively assess survival times and factors influencing survival times.AnimalsDogs diagnosed with DA from January 2007 to June 2017.MethodsDisseminated aspergillosis case data were retrieved from 13 Australian veterinary referral centers, with a diagnosis confirmed with culture or PCR. Factors influencing survival time after diagnosis were quantified using a Cox proportional hazards regression model.ResultsThirty‐four dogs met the study inclusion criteria. Twenty‐two dogs were treated with antifungal treatment and 12 dogs received no antifungal treatment. Accounting for censoring of dogs that were either still alive on the date of data collection or were loss to follow‐up, dogs treated with itraconazole alone (n = 8) had a median survival time (MST) of 63 (95% CI: 20−272) days compared to 830 (95% CI: 267‐1259) days for the n = 14 dogs that received multimodal antifungal therapy (χ2 test statistic 8.6; df = 1; P < .01). The daily hazard of death (DHOD) for dogs with abnormally high serum creatinine concentration at the time of diagnosis was 7.4 (95% CI: 1.9‐29) times that of dogs with serum creatinine within the reference interval.Conclusion and Clinical ImportanceSerum creatinine concentration at the time of diagnosis is a useful prognostic indicator for survival after a diagnosis of DA. The MST for dogs treated with multimodal antifungal therapy is longer than itraconazole alone and warrant further investigation (P < .01).